Cancer drug development: Problems and opportunities

被引：0
|
作者：
Markman, M
机构：
[1] Cleveland Clin Fdn, Dept Hematol Med Oncol, Cleveland, OH 44195 USA
[2] Cleveland Clin, Ctr Canc, Cleveland, OH 44106 USA
来源：
DRUG INFORMATION JOURNAL | 1998年 / 32卷 / 01期
关键词：
cancer; oncologic drug development; pharmaceutical industry;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
The pharmaceutical industry must direct additional focus on the development of agents to prevent or minimize symptoms of cancer and its treatment, and maximize the qualify of life of cancer patients. This paper covers the current status of cancer chemotherapy, opportunties for intervention supportive care measures, and challenges to the pharmaceutical industry in oncologic drug development.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [21] Novel drug development opportunities for heparin
    Rebecca Lever
    Clive P. Page
    Nature Reviews Drug Discovery, 2002, 1 : 140 - 148
  • [22] Novel drug development opportunities for heparin
    Lever, R
    Page, CR
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (02) : 140 - 148
  • [23] Pediatric Drug Development: Challenges and Opportunities
    Spadoni, Cesare
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2019, 90 : 119 - 122
  • [24] Drug development and discovery: challenges and opportunities
    Moridani, Majid
    Harirforoosh, Sam
    DRUG DISCOVERY TODAY, 2014, 19 (11) : 1679 - 1681
  • [25] Challenges and opportunities of pharmacogenetics in drug development
    March, Ruth
    PERSONALIZED MEDICINE, 2006, 3 (02) : 195 - 206
  • [26] Challenges and opportunities in drug discovery and development
    Kumar, Nikhil
    CURRENT SCIENCE, 2014, 107 (09): : 1367 - 1367
  • [27] Obstacles and opportunities in new drug development
    Kaitin, K. I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 210 - 212
  • [28] Challenges and opportunities in NASH drug development
    Stephen A. Harrison
    Alina M. Allen
    Julie Dubourg
    Mazen Noureddin
    Naim Alkhouri
    Nature Medicine, 2023, 29 : 562 - 573
  • [29] Challenges and Opportunities in Cancer Drug Resistance
    Ward, Richard A.
    Fawell, Stephen
    Floc'h, Nicolas
    Flemington, Vikki
    McKerrecher, Darren
    Smith, Paul D.
    CHEMICAL REVIEWS, 2021, 121 (06) : 3297 - 3351
  • [30] Challenges and opportunities with modelling and simulation in drug discovery and drug development
    Lave, T.
    Parrott, N.
    Grimm, H. P.
    Fleury, A.
    Reddy, M.
    XENOBIOTICA, 2007, 37 (10-11) : 1295 - 1310
12345